tetano
Editor, Senior Moderator
Clin J Gastroenterol
. 2023 Apr 7.
doi: 10.1007/s12328-023-01794-x. Online ahead of print.
Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review
Masayuki Ueno[SUP] 1 2 [/SUP], Hiroyuki Takabatake[SUP] 3 [/SUP], Junya Itakura[SUP] 4 [/SUP], Rio Fujita[SUP] 3 5 [/SUP], Takahisa Kayahara[SUP] 3 [/SUP], Youichi Morimoto[SUP] 3 [/SUP], Kenji Notohara[SUP] 4 [/SUP], Motowo Mizuno[SUP] 3 [/SUP]
Affiliations
Abstract
Several vaccines have been developed for coronavirus disease 2019 (COVID-19) and are used worldwide. Here we report a case of severe acute hepatitis induced by COVID-19 vaccination. A 54-year-old woman received two doses of the Pfizer-BioNTech COVID-19 mRNA vaccine and an additional dose of the Moderna COVID-19 mRNA vaccine. Seven days after the third dose, she noticed fatigue, appetite loss and dark urine. Laboratory tests were consistent with severe liver injury and jaundice. Anti-smooth muscle antibody and HLA-DR4 were positive; thus, we suspected that she had autoimmune hepatitis (AIH). Intravenous methylprednisolone followed by oral prednisolone were administered. Because remission was not achieved, we performed percutaneous liver biopsy. Histologically, pan-lobular inflammation with moderate infiltration of lymphocytes and macrophages, interface hepatitis, and rosette formation were present. We regarded these findings as confirmation of the diagnosis of AIH. As she had not responded to corticosteroids, we added azathioprine. Liver biochemistry tests gradually improved, and prednisolone could be tapered without relapse of AIH. Dozens of cases of AIH after COVID-19 vaccination have been reported. Corticosteroids were effective in most cases, but some patients have died from liver failure after vaccination. This case illustrates the efficacy of azathioprine for steroid-refractory AIH induced by COVID-19 vaccination.
Keywords: Adverse drug reactions; Autoimmune hepatitis; Azathioprine; SARS-Cov-2; Vaccines.
. 2023 Apr 7.
doi: 10.1007/s12328-023-01794-x. Online ahead of print.
Corticosteroid-refractory autoimmune hepatitis after COVID-19 vaccination: a case report and literature review
Masayuki Ueno[SUP] 1 2 [/SUP], Hiroyuki Takabatake[SUP] 3 [/SUP], Junya Itakura[SUP] 4 [/SUP], Rio Fujita[SUP] 3 5 [/SUP], Takahisa Kayahara[SUP] 3 [/SUP], Youichi Morimoto[SUP] 3 [/SUP], Kenji Notohara[SUP] 4 [/SUP], Motowo Mizuno[SUP] 3 [/SUP]
Affiliations
- PMID: 37029249
- DOI: 10.1007/s12328-023-01794-x
Abstract
Several vaccines have been developed for coronavirus disease 2019 (COVID-19) and are used worldwide. Here we report a case of severe acute hepatitis induced by COVID-19 vaccination. A 54-year-old woman received two doses of the Pfizer-BioNTech COVID-19 mRNA vaccine and an additional dose of the Moderna COVID-19 mRNA vaccine. Seven days after the third dose, she noticed fatigue, appetite loss and dark urine. Laboratory tests were consistent with severe liver injury and jaundice. Anti-smooth muscle antibody and HLA-DR4 were positive; thus, we suspected that she had autoimmune hepatitis (AIH). Intravenous methylprednisolone followed by oral prednisolone were administered. Because remission was not achieved, we performed percutaneous liver biopsy. Histologically, pan-lobular inflammation with moderate infiltration of lymphocytes and macrophages, interface hepatitis, and rosette formation were present. We regarded these findings as confirmation of the diagnosis of AIH. As she had not responded to corticosteroids, we added azathioprine. Liver biochemistry tests gradually improved, and prednisolone could be tapered without relapse of AIH. Dozens of cases of AIH after COVID-19 vaccination have been reported. Corticosteroids were effective in most cases, but some patients have died from liver failure after vaccination. This case illustrates the efficacy of azathioprine for steroid-refractory AIH induced by COVID-19 vaccination.
Keywords: Adverse drug reactions; Autoimmune hepatitis; Azathioprine; SARS-Cov-2; Vaccines.